openPR Logo
Press release

Global Autologous Cell Therapy Market Forecasted To Grow At A CAGR Of 23.39% Between The Period 2017 - 2021

01-16-2018 10:03 AM CET | Fashion, Lifestyle, Trends

Press release from: Autologous Cell Therapy Market

Market Research Report

Market Research Report

Researchmoz added Most up-to-date research on "Global Autologous Cell Therapy Market Forecasted To Grow At A CAGR Of 23.39% Between The Period 2017 - 2021" to its huge collection of research reports.

Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds from various quarters.

Technavios analysts forecast the global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global autologous cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of autologous stem cell as well non-stem cell products.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1140762

Key vendors
Brainstorm Cell Therapeutics
Holostem Advanced Therapies
Osiris Therapeutics
Valeant
Vericel Corporation

Other prominent vendors
AbbVie
American CryoStem
AM-Pharma
Anterogen
apceth Biopharma
Astellas Pharma
Athersys
Baxter International
Beike Biotechnology
BIOTIME
bluebird bio
Bristol-Myers Squibb
Brainxell
Caladrius Biosciences
Cellular Biomedicine Group
Cellular Dynamics International (a subsidiary of Fujifilm)
Cesca Therapeutics
CHA Biotech
Chugai Pharmaceutical
Citospin
Corestem
Cytori Therapeutics
Daiichi Sankyo
Fujifilm
Gamida Cell
Global Stem Cells Group
Grupo Ferrer Internacional
GlaxoSmithKline
Hemostemix
Histocell
International Stem Cell
Ivy Institute of Stem Cells
Japan Regenerative Medicine
Kangstem Biotech
Kiadis Pharma
Laboratorios Salvat
MEDIPOST
Mesoblast
Nuo Therapeutics
Opsis Therapeutics
Pharmicell
Pluristem Therapeutics
Promethera Biosciences
Q Therapeutics
ReNeuron
RHEACELL
Salus Medical Solutions
Sangamo Therapeutics
Shire
Steminent Biotherapeutics
Sumitomo Dainippon Pharma
Taiwan Bio Therapeutics
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Thoratec Corporation
TiGenix
Translational Biosciences
TWO CELLS
U.S. Stem Cell
ViaCyte
VistaGen Therapeutics

Browse TOC @ https://www.researchmoz.us/global-autologous-cell-therapy-market-2017-2021-report.html/toc

Market driver
Increasing demand for effective drugs for cardiac and degenerative disorders
For a full, detailed list, view our report

Market challenge
Critical ethical challenges with respect to stem cell research
For a full, detailed list, view our report

Market trend
Private funding will fuel market growth
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger @ http://summaryofmarketresearchreports.blogspot.in/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Autologous Cell Therapy Market Forecasted To Grow At A CAGR Of 23.39% Between The Period 2017 - 2021 here

News-ID: 901460 • Views:

More Releases from Autologous Cell Therapy Market

Autologous Cell Therapy Market to Show Staggering CAGR of 21.9% by 2024 as Incidences of Cancer Rise Worldwide
Autologous Cell Therapy Market to Show Staggering CAGR of 21.9% by 2024 as Incid …
Global Autologous Cell Therapy Market: Overview This report provides in-depth region wise and country wise analysis of the autologous cell therapy market. Stakeholders of this report include manufacturers of cell therapy products, raw material suppliers, cancer drug processing companies, and new players planning to enter the market. The report provides qualitative and quantitative analysis of the global autologous cell therapy market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market
Global Autologous Cell Therapy Market Overview, Development and Scenario by Companies | BrainStorm Cell Therapeutics, Caladrius Biosciences, Inc., TiGenix N.V. and Vericel Corporation
Global Autologous Cell Therapy Market Overview, Development and Scenario by Comp …
Researchmoz added Most up-to-date research on "Global Autologous Cell Therapy Market Overview, Development and Scenario by Companies | BrainStorm Cell Therapeutics, Caladrius Biosciences, Inc., TiGenix N.V. and Vericel Corporation" to its huge collection of research reports. This report provides in-depth region wise and country wise analysis of the autologous cell therapy market. Stakeholders of this report include manufacturers of cell therapy products, raw material suppliers, cancer drug processing companies, and new
Global Autologous Cell Therapy Market To Grow At A CAGR Of 23.39% During The Period 2017-2021
Global Autologous Cell Therapy Market To Grow At A CAGR Of 23.39% During The Per …
Researchmoz added Most up-to-date research on "Global Autologous Cell Therapy Market 2017-2021" to its huge collection of research reports. Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds

All 4 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant